Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Risk of Diabetes in Combined Metabolic Abnormalities and Body Mass Index Categories Publisher Pubmed



Janghorbani M1, 2 ; Soltanian N1 ; Sirous M3 ; Amini M1 ; Iraj B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Departement of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews Published:2016


Abstract

Aim The present study was designed to estimate the progression rates from combination of normal weight, overweight, obesity, and number of metabolic abnormalities (MA) to type 2 diabetes (T2D) in a non-diabetic high risk population in Isfahan, Iran. Methods A total of 1869 non-diabetic first-degree relatives (FDR) of patients with T2D 30–70 years old were examined and followed for a mean (SD) of 7.3 (2.2) years for T2D incidence. At baseline and through follow-up, participants underwent a standard 75-g 2-h oral glucose tolerance test. Results The metabolically healthy overweight and obese at baseline were associated with incidence of T2D, independently of age and gender. Any one MA increased the risk of developing T2D among normal weight, overweight and obese individuals. Those with normal weight and ≥3 MA were over 20 times (odds ratios (OR) 20.21; 95% confidence intervals (CI) 2.4, 170.4) and those with overweight and ≥3 MA 22.5 times (OR 22.5; 95% CI 3.0, 167.0) and obese with ≥3 MA were 25.4 times (OR 25.4; 95% CI 3.4, 187) more likely to develop T2D than those with normal weight and without MA. Compared with participants without MA, obese individuals with concomitant MA were not significantly more likely to progress to T2D. Conclusion Our data provide further evidence that normal weight, overweight and obese individuals with MA had a higher risk of incident T2D than normal weight individuals without MA. © 2015 Diabetes India
Related Docs
View other Related Docs
1. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
2. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Annals of Nutrition and Metabolism (2016)
3. Comparison of Metabolic Syndrome With Glucose Measurement for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2009)
4. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)
5. Comparison of Body Mass Index With Abdominal Obesity Indicators and Waist-To-Stature Ratio for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Obesity Research and Clinical Practice (2010)
6. Weight Status of the First-Degree Relatives of Patients With Type 2 Diabetes Based on the Glucose Tolerance Test, Journal of Research in Medical Sciences (2012)
7. Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population With Normal Glucose Tolerance, Metabolic Syndrome and Related Disorders (2012)
8. Anthropometric Indices Predicting Incident Type 2 Diabetes in an Iranian Population: The Isfahan Cohort Study, Diabetes and Metabolism (2013)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (48)
Roya Kelishadi (41)
Other Related Docs
9. Utility of Hypertriglyceridemic Waist Phenotype for Predicting Incident Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Journal of Diabetes Investigation (2016)
10. Associations of Hip Circumference and Height With Incidence of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Acta Diabetologica (2012)
11. Determinants of Incident Prediabetes and Type 2 Diabetes in a 7-Year Cohort in a Developing Country: The Isfahan Cohort Study, Journal of Diabetes (2015)
12. The Visceral Adiposity Index in Comparison With Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes, Canadian Journal of Diabetes (2016)
13. Comparison of Glycated Hemoglobin With Fasting Plasma Glucose in Definition of Glycemic Component of the Metabolic Syndrome in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2012)
14. The Prevalence of Impaired Fasting Glucose and Type 2 Diabetes in a Population-Based Sample of Overweight/Obese Children in the Middle East, Pediatric Diabetes (2010)
15. Low-Density Lipoprotein Cholesterol and Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2018)
16. Normal Fasting Plasma Glucose and Risk of Prediabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2011)
17. Evaluation of the Finnish Diabetes Risk Score (Findrisc) As a Screening Tool for the Metabolic Syndrome, The review of diabetic studies : RDS (2013)
18. Transcription Factor 7-Like 2 Polymorphism and Context-Specific Risk of Metabolic Syndrome, Type 2 Diabetes, and Dyslipidemia, Journal of Research in Medical Sciences (2017)
19. Finnish Diabetes Risk Score to Predict Type 2 Diabetes in the Isfahan Diabetes Prevention Study, Diabetes Research and Clinical Practice (2013)
20. Systematic Review and Meta-Analysis of Age at Menarche and Risk of Type 2 Diabetes, Acta Diabetologica (2014)
21. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
22. Comparison of Fasting Glucose With Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2009)
23. Factors Associated With Progression to Pre-Diabetes: A Recurrent Events Analysis, Eating and Weight Disorders (2020)
24. Diabetes and All-Cause Mortality, a 18-Year Follow-Up Study, Scientific reports (2020)
25. Diabetes and Impaired Glucose Regulation in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran: Prevalence and Risk Factors, Review of Diabetic Studies (2007)
26. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients With Type Ii Diabetes, Journal of Kerman University of Medical Sciences (2013)
27. People With Impaired Glucose Tolerance and Impaired Fasting Glucose Are Similarly Susceptible to Cardiovascular Disease: A Study in First-Degree Relatives of Type 2 Diabetic Patients, Annals of Nutrition and Metabolism (2010)
28. Normalization of Glucose Intolerance in First-Degree Relatives of Patients With Type 2 Diabetes, Diabetes Research and Clinical Practice (2010)
29. Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors, Metabolic Syndrome and Related Disorders (2007)
30. Relationship Between Dietary Patterns and Incidence of Type 2 Diabetes, International Journal of Preventive Medicine (2019)
31. Patterns and Predictors of Long-Term Weight Change in Patients With Type 2 Diabetes Mellitus, Annals of Nutrition and Metabolism (2009)
32. Dairy Intake in Relation to Metabolic Health Status in Overweight and Obese Adolescents, Scientific Reports (2022)
33. Effects of Gender and Height on the Oral Glucose Tolerance Test: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2008)
34. Association Between Type 2 Diabetes and Different Types of Dietary Fats: A Case-Control Study, Clinical Nutrition ESPEN (2023)
35. Incidence of Type 2 Diabetes by Hba1c and Ogtt: The Isfahan Diabetes Prevention Study, Acta Diabetologica (2012)
36. Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2016)
37. Glucose and the Risk of Hypertension in First-Degree Relatives of Patients With Type 2 Diabetes, Hypertension Research (2015)
38. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
39. Progression From Optimal Blood Glucose and Pre-Diabetes to Type 2 Diabetes in a High Risk Population With or Without Hypertension in Isfahan, Iran, Diabetes Research and Clinical Practice (2015)
40. Incidence of Metabolic Syndrome and Its Risk Factors Among Type 2 Diabetes Clinic Attenders in Isfahan, Iran, Endokrynologia Polska (2012)
41. Progression to Impaired Glucose Metabolism in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran, Diabetes/Metabolism Research and Reviews (2009)
42. First-Degree Relatives of Patients With Type 2 Diabetes Mellitus and Risk of Non-Alcoholic Fatty Liver Disease, Review of Diabetic Studies (2007)
43. Comparison of Systolic and Diastolic Blood Pressure With Pulse Pressure and Mean Arterial Pressure for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Endokrynologia Polska (2011)
44. Assessing the Predictive Value of Insulin Resistance Indices for Metabolic Syndrome Risk in Type 2 Diabetes Mellitus Patients, Scientific Reports (2024)
45. Body Weight Changes and Diabetes Mellitus Incident: A Cohort Study From the Middle East, Journal of Preventive Medicine and Hygiene (2023)
46. Low-Carbohydrate-Diet Score and Metabolic Syndrome: An Epidemiologic Study Among Iranian Women, Nutrition (2015)
47. Dietary Energy Density and the Metabolic Syndrome Among Iranian Women, European Journal of Clinical Nutrition (2011)
48. Serum Uric Acid Level and Its Association With Cardiometabolic Risk Factors in Prediabetic Subjects, Journal of Research in Medical Sciences (2014)
49. Adherence to a Healthy Diet and Odds of Metabolic Syndrome: A Cross-Sectional Study, Clinical Nutrition ESPEN (2023)
50. Novel Anthropometric Indices for Predicting Type 2 Diabetes Mellitus, BMC Public Health (2024)